Clinical Trial Detail

NCT ID NCT02303678
Title D2C7 for Adult Patients With Recurrent Malignant Glioma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Darell D. Bigner, MD, PhD
Indications

malignant glioma

Therapies

D2C7-IT

Age Groups: adult senior

No variant requirements are available.